FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
771016011 One (qualifier value) en Fully specified name Inactive Only initial character case insensitive (core metadata concept) SNOMED CT core
3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
143801000052115 ett sv Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Sweden NRC maintained module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
1 (qualifier value) Is a General adjectival modifier false Inferred relationship Some
1 (qualifier value) Is a Number (qualifier value) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely pizotifen 50 microgram/1 milliliter conventional release oral solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Glucose 40 mg/mL and sodium chloride 1.8 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely didanosine 1.67 milligram/1 milliliter conventional release oral solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Hydromorphone hydrochloride 4 mg/mL solution for injection räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Hydromorphone hydrochloride 4 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely sumatriptan 10 milligram/1 actuation conventional release nasal spray (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Adrenaline 1 mg/mL eye solution har täljarvärde för koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Adrenaline 1 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Adrenaline 1 mg/mL eye solution räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Glucose 50 mg/mL and sodium chloride 1.8 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely didanosine 2.5 milligram/1 milliliter conventional release oral solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely acetylcholine chloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely acetylcholine chloride 10 milligram/1 milliliter conventional release eye solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Salicylic acid 170 mg/mL cutaneous solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Salicylic acid 170 mg/mL cutaneous solution räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Rabbit anti-human T-lymphocyte globulin 25 mg powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Rabbit anti-human T-lymphocyte globulin 25 mg powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Adrenaline 2.5 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Adrenaline 2.5 mg/mL eye solution räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Diazepam 5 mg/mL suspension for injection räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Diazepam 5 mg/mL suspension for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely rasburicase 7.5 milligram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Hydrocodone bitartrate 500 microgram/mL and paracetamol 21.7 mg/mL oral solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Ecothiopate (as ecothiopate iodide) 1.25 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Ecothiopate (as ecothiopate iodide) 1.25 mg/mL eye solution räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Rivastigmine 192 microgram/hour prolonged-release transdermal patch har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Rivastigmine 192 microgram/hour prolonged-release transdermal patch räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Adrenaline (as adrenaline acid tartrate) 500 microgram/mL and guanethidine 2.5 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely etidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely hydrocodone bitartrate 333 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Dextromethorphan 7.5 mg oromucosal lozenge har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Dextromethorphan 7.5 mg oromucosal lozenge räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Paracetamol 32 mg/mL oral solution räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Paracetamol 32 mg/mL oral solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Hetastarch 60 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Hetastarch 60 mg/mL solution for injection räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Rivastigmine 396 microgram/hour prolonged-release transdermal patch räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Rivastigmine 396 microgram/hour prolonged-release transdermal patch har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution har täljarvärde för koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Adrenaline (as adrenaline acid tartrate) 1 mg/mL and guanethidine 5 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Vardenafil (as vardenafil hydrochloride) 10 mg orodispersible tablet har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Vardenafil (as vardenafil hydrochloride) 10 mg orodispersible tablet räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Methoxsalen 20 microgram/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Methoxsalen 20 microgram/mL solution for injection räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Product containing precisely hydrocodone bitartrate 500 microgram/1 milliliter and paracetamol 33.3 milligram/1 milliliter conventional release oral solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Methylcellulose 10 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Methylcellulose 10 mg/mL eye solution räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely sodium picosulfate 66.7 microgram/1 milliliter conventional release oral solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely sodium picosulfate 66.7 microgram/1 milliliter conventional release oral solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Levoleucovorin (as levoleucovorin calcium) 50 mg powder for solution for injection vial räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Levoleucovorin (as levoleucovorin calcium) 50 mg powder for solution for injection vial har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Adrenaline (as adrenaline acid tartrate) 5 mg/mL and guanethidine 10 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Aripiprazole 7.5 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Aripiprazole 7.5 mg/mL solution for injection räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely ferrous sulfate 116 milligram/1 milliliter conventional release oral solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely ferrous sulfate 116 milligram/1 milliliter conventional release oral solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely sodium nitroprusside 25 milligram/1 milliliter conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely sodium nitroprusside 25 milligram/1 milliliter conventional release solution for injection (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely prilocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely prilocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Somatropin 10 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Somatropin 10 mg/mL solution for injection räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and etidocaine hydrochloride 15 milligram/1 milliliter conventional release solution for injection (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely enfuvirtide 90 milligram/1 vial powder for conventional release solution for injection (clinical drug) har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely enfuvirtide 90 milligram/1 vial powder for conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Hyoscine (as hyoscine hydrobromide) 1.25 mg/mL eye solution räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Piroxicam 10 mg oral tablet har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Piroxicam 10 mg oral tablet räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely paracetamol 16 milligram/1 milliliter conventional release oral solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely paracetamol 16 milligram/1 milliliter conventional release oral solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely morphine sulfate 10 milligram/1 milliliter conventional release oral solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely morphine sulfate 10 milligram/1 milliliter conventional release oral solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Somatropin 4 mg/mL solution for injection räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Somatropin 4 mg/mL solution for injection har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Levobetaxolol 5 mg/mL eye suspension har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Levobetaxolol 5 mg/mL eye suspension räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
cefpodoxim 10 milligram/milliliter, oral suspension har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
cefpodoxim 10 milligram/milliliter, oral suspension räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely scopolamine (as scopolamine hydrobromide) 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Morphine sulfate 100 mg rectal suppository har nämnarvärde som visar styrka False 1 (qualifier value) Inferred relationship Some 1
Morphine sulfate 100 mg rectal suppository räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely zoledronic acid 50 microgram/1 milliliter conventional release solution for injection (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 1
Product containing precisely zoledronic acid 50 microgram/1 milliliter conventional release solution for injection (clinical drug) räkning av bas i aktiv ingrediens False 1 (qualifier value) Inferred relationship Some
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) har nämnarvärde som visar koncentrationsstyrka False 1 (qualifier value) Inferred relationship Some 2

Start Previous Page 195 of 215 Next End


This concept is not in any reference sets

Back to Start